FDA Approves New Lice Treatment

The U.S. Food and Drug Administration (FDA) recently approved Natroba® (spinosad) as a new topical treatment for head lice in patients who are least four years old.

Lice (also called pediculosis) are tiny, parasitic insects that feed on blood from their hosts, which may be human. When a human becomes infected with lice, it is not considered a major health concern. However, it typically causes the skin to become red and itchy. Lice are easily spread through close personal contact with an infected person or his/her belongings.

Natroba® is applied to the person's scalp or hair. Common side effects may include red or irritated eyes or skin.

Several herbs and supplements, including American pawpaw, hibiscus, quassia and tea tree oil, have been suggested as possible treatment options for lice. However, based on the available evidence, it is unclear if these integrative therapies are effective.

References
1.Natural Standard: The Authority on Integrative Medicine. www.naturalstandard.com
2.U.S. Food and Drug Administration (FDA). www.fda.gov

http://www.depsyl.com/

http://back2basicnutrition.com/

http://bionutritionalresearch.olhblogspace.com/